文献库，生知库 | 链接生命科学的每一步

Kerri Hagemann, Kristoffer Riecken, Johannes M Jung, Heike Hildebrandt, Stephan Menzel, Madeleine J Bunders, Boris Fehse, Friedrich Koch-Nolte, Fabian Heinrich, Sven Peine, Julian Schulze Zur Wiesch, Thomas T Brehm, Marylyn M Addo, Marc Lütgehetmann, Marcus Altfeld

代谢

信号转导

免疫

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial

度拉糖肽 3.0 mg 和 4.5 mg 在 65 岁以下和 65 岁及以上患者中的疗效和安全性：AWARD-11 试验的事后分析

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14469

Frias, Juan P; Bonora, Enzo; Nevárez Ruiz, Luis; Hsia, Stanley H; Jung, Heike; Raha, Sohini; Cox, David A; Bethel, M Angelyn; Konig, Manige

发表日期：2021

文献求助收藏

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

一项关于度拉糖肽和利拉鲁肽治疗2型糖尿病患者健康结局的真实世界观察性前瞻性研究（TROPHIES）：设计和基线特征

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-021-01076-0

García-Pérez, Luis-Emilio; Boye, Kristina S; Rosilio, Myriam; Jung, Heike; Heitmann, Elke; Norrbacka, Kirsi; Federici, Marco Orsini; Gentilella, Raffaella; Guerci, Bruno; Giorgino, Francesco; Aigner, Ulrich; Sapin, Hélène

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11

每周一次 3.0 mg 和 4.5 mg 度拉糖肽的胃肠道耐受性：AWARD-11 研究中恶心、呕吐和腹泻发生率和患病率的事后分析

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-021-01140-9

Van, Joanna; Frias, Juan P; Bonora, Enzo; Raha, Sohini; Meyer, Jarrett; Jung, Heike; Cox, David; Konig, Manige; Peleshok, Jennifer; Bethel, M Angelyn

发表日期：2021

文献求助收藏

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

型糖尿病患者使用度拉糖肽和利拉糖肽治疗的健康结局真实世界观察性前瞻性研究 (TROPHIES)：基线患者报告结局

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-020-00908-9

Boye, Kristina S; Sapin, Hélène; García-Pérez, Luis-Emilio; Rosilio, Myriam; Orsini Federici, Marco; Heitmann, Elke; Jung, Heike; Aigner, Ulrich; Guerci, Bruno; Giorgino, Francesco; Norrbacka, Kirsi

A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment

全激酶组 RNAi 筛选确定 ALK 是使神经母细胞瘤细胞对 HDAC8 抑制剂治疗敏感的靶点

期刊:Cell Death and Differentiation

影响因子:13.7

doi:10.1038/s41418-018-0080-0

Jing Shen, Sara Najafi, Sina Stäble, Johannes Fabian, Emily Koeneke, Fiona R Kolbinger, Jagoda K Wrobel, Benjamin Meder, Martin Distel, Tino Heimburg, Wolfgang Sippl, Manfred Jung, Heike Peterziel, Dominique Kranz, Michael Boutros, Frank Westermann, Olaf Witt, Ina Oehme2

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

对接受生长激素治疗的成年垂体功能减退患者原发性癌症的评估：来自垂体功能减退控制和并发症研究的分析

期刊:European Journal of Endocrinology

影响因子:5.2

doi:10.1530/EJE-11-0286

Child, Christopher J; Zimmermann, Alan G; Woodmansee, Whitney W; Green, Daniel M; Li, Jian J; Jung, Heike; Erfurth, Eva Marie; Robison, Leslie L

Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain.

兴奋性氨基酸受体介导的神经元到胶质细胞的信号传导调节神经内分泌脑星形胶质细胞中的 ErbB 受体功能

期刊:Journal of Neuroscience

影响因子:4

doi:10.1523/JNEUROSCI.23-03-00915.2003

Dziedzic Barbara, Prevot Vincent, Lomniczi Alejandro, Jung Heike, Cornea Anda, Ojeda Sergio R

Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients

SARS-CoV-2 感染者和疫苗接种者中的自然杀伤细胞介导的 ADCC

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial

度拉糖肽 3.0 mg 和 4.5 mg 在 65 岁以下和 65 岁及以上患者中的疗效和安全性：AWARD-11 试验的事后分析

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

一项关于度拉糖肽和利拉鲁肽治疗2型糖尿病患者健康结局的真实世界观察性前瞻性研究（TROPHIES）：设计和基线特征

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11

每周一次 3.0 mg 和 4.5 mg 度拉糖肽的胃肠道耐受性：AWARD-11 研究中恶心、呕吐和腹泻发生率和患病率的事后分析

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

型糖尿病患者使用度拉糖肽和利拉糖肽治疗的健康结局真实世界观察性前瞻性研究 (TROPHIES)：基线患者报告结局

A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment

全激酶组 RNAi 筛选确定 ALK 是使神经母细胞瘤细胞对 HDAC8 抑制剂治疗敏感的靶点

Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study

对接受生长激素治疗的成年垂体功能减退患者原发性癌症的评估：来自垂体功能减退控制和并发症研究的分析

Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain.

兴奋性氨基酸受体介导的神经元到胶质细胞的信号传导调节神经内分泌脑星形胶质细胞中的 ErbB 受体功能